Objectives: The objective of the study was to obtain pilot data comparing hypnotherapy and behavioral therapy (hypnotherapy) to behavioral therapy alone (behavioral therapy) in overactive bladder (OAB) treatment.
O veractive bladder (OAB) syndrome is a functional disorder of bladder storage and is defined by the International Continence Society as urinary urgency, usually accompanied by frequency and nocturia, with or without urinary incontinence. 1 Overactive bladder is common and affects approximately 17% of women in the United States. 2 It is also expensive and will cost society $7.2 billion per annum by 2015. 3 On a personal level, not only do patients with OAB experience decreased selfesteem, but it also results in significant distress and embarrassment for family members. 4 Because of the scope of its effects, OAB has spawned development of numerous therapies, many pharmacologic. Although medications to treat OAB are efficacious in clinical trials, in clinical practice they are costly and continuation rates at 12 months have been reported to be as low as 13%. 5 Adverse effects of medications, including dry mouth and constipation, are well recognized factors that contribute to their discontinuation.
Behavioral therapy, including fluid management, timed voiding, and suppression of urge with distraction or relaxation, has been equally or more effective than medications in treatment of older women with OAB. 6 Behavioral therapy is an intervention based on the premise that maladaptive behavior can be modified or unlearned. Success of bladder retraining ''is based on the assumption that conscious efforts to suppress sensory stimuli will reestablish cortical control over an uninhibited bladderI reestablishing normal voiding patterns.'' 7 Behavioral therapy's proven effectiveness in OAB treatment underscores the importance of the mind's central role in response to and control of this syndrome.
Hypnotherapy, similar to behavioral therapy, may be used to modify behavior and has potential in treating OAB. Hypnosis, a state of inner absorption, concentration, and focused attention, has been used to promote ''suggestions for changes in subjective experience, alterations inI emotion, thought, or behavior.'' 8 To date, a single case series has reported hypnotherapy's effectiveness in treating women with OAB. 9 In this series, 50 participants with urgency incontinence completed 12 weekly hypnotherapy sessions. Following treatment, 86% of women in this noncomparative study reported that they were improved or cured; 29 were ''entirely symptom-free,'' and 14 were ''considerably improved.'' 9 Patient-reported outcomes and other validated measures were not included in the report. The purpose of our current pilot trial was to further explore hypnotherapy's potential role in OAB treatment. Our objective was to obtain preliminary efficacy data using validated outcomes to compare hypnotherapy to a proven standard treatment, behavioral therapy.
MATERIALS AND METHODS
In this exploratory study, we compared hypnotherapy and behavioral therapy to behavioral therapy alone in treatment of OAB. Outcome measures included results of the Patient Global Impression of Improvement (PGI-I), 10 the OAB-q 11 Short Form (OAB-q SF) questionnaires, and voiding frequency based on voiding diaries. The study was approved by the University of New Mexico Hospital Internal Review Board (HRRC no. 08-102). All subjects gave written informed consent before study participation.
Women who presented to the University of New Mexico Hospital Urogynecology Clinic with complaints of urinary urgency and frequency with or without incontinence were invited to participate in the study. Women with untreated urinary tract infections or vaginal descent past the hymen with Valsalva or elevated postvoid residuals were excluded from participation. NonYEnglish-speaking women, pregnant or incarcerated women, women younger than 18 years, or those with a history of psychosis were also excluded. Potential subjects completed the OAB Awareness Tool, a questionnaire validated to identify women with bothersome OAB symptoms. 12 Women with scores of 8 or greater were eligible for enrollment in this study. Scores of 8 or greater have been found to be sensitive and specific in screening for women with OAB. 12 This pilot study was a parallel-group, randomized controlled trial (''Hypnotherapy for Treatment of Overactive Bladder,'' Clinical Trials.gov, NCT #00793611). After informed consent was obtained, women were randomized to the hypnotherapy group or to the behavioral therapy group. A computergenerated allocation sequence was used, and subjects were assigned to either of the 2 interventions. Block randomization in groups of 10 in a final 1:1 ratio ensured similar distributions of subjects between groups. Allocation concealment was performed. Assignments were kept in sequentially numbered, tamperproof, sealed opaque envelopes in the University of New Mexico Clinical Trials Science Center (CTSC). Subjects were sent to the CTSC after study enrollment and randomized by CTSC personnel who distributed the envelopes and notified participants of their group assignment. The subjects, the hypnotherapist, and the research nurses who administered the interventions were not blinded to the treatment interventions. Data entry personnel and investigators who performed data analysis were blinded to subjects' group assignments.
Before randomization and treatment initiation, subjects answered the OAB-q SF questionnaire, a questionnaire validated for use in OAB subjects, 11 which consists of a 6-item symptom bother scale and 13-item health-related quality-of-life scale. Subjects also underwent a pelvic examination to ensure that the leading edge of the vagina did not descend past the hymen with Valsalva and answered pertinent demographic and medical history questions. Following randomization, but before initiating treatment, subjects recorded voiding frequency with a 3-day voiding diary. The principal investigator instructed both the research nurses and the hypnotherapist regarding an approach to discussion of behavioral interventions (review of voiding diaries, fluid management, voiding schedules, time voiding, distraction techniques, and pelvic floor exercise, as noted subsequently). The research nurses and hypnotherapist had the freedom to customize counseling to fit individual patient needs such as addressing OAB triggers and stressors and suggesting changes to prior ineffective coping mechanisms. Subjects randomized to behavioral therapy were scheduled to see a research nurse for three 30-to 60-minute counseling sessions over 6 to 8 weeks. At the first visit, the subject and research nurse reviewed the voiding diary, discussed fluid management, and suggested changes in voiding schedules. Timed voiding, a method of desensitization resulting in incremental increases in time between voids, was initiated. Urge distraction techniques were also introduced during these sessions. Pelvic floor exercises were discussed, and their practice emphasized. Similar discussions occurred during the second and third sessions. Subjects randomized to hypnotherapy were scheduled to see a certified clinical hypnotherapist (R.E.S.) for three 60-minute sessions over 6 to 8 weeks. The hypnotherapist is a board-certified hypnotherapist (board certification requires 9300 hours of hypnotherapy training from a state-licensed school, successful completion of a written test, and review of clinical skills). During each session, the hypnotherapist replicated the patient counseling provided in the behavioral therapy session, including review of the voiding diary, timed voiding, and pelvic floor exercise. In addition, during the first hypnotherapy session, the hypnotherapist explained hypnotherapeutic principles and used illustrations of the bladder to help visualize the goal of relaxing and stretching the bladder, and subjects underwent hypnotic induction using guided imagery (for bladder relaxation) and therapeutic suggestion (regarding responses to OAB symptoms). These individualized therapeutic suggestions and imagery sessions were developed by the clinical hypnotherapist based on statements provided by the subjects to the hypnotherapist regarding their perceptions and impressions of their OAB problems. Subjects were instructed to practice these relaxation responses at home before the next session. During the second session, timed voiding and pelvic floor exercise were again discussed. Emotional responses to OAB symptoms were discussed, and hypnotic induction performed. Subjects were taught guided imagery for use as a relaxation technique in response to urinary urgency. During hypnosis, potential emotions blocking OAB improvement were identified. Subjects were instructed on self-hypnosis and were encouraged to practice these daily until the next session. During the third session, OAB symptoms and voiding patterns were reviewed. Subjects were hypnotized and were read a standardized guided imagery script on health and healing.
At the end of the hypnotherapy and behavioral-therapyYalone treatments, subjects repeated a 3-day voiding diary, completed the OAB-q SF, and, in addition, answered the PGI-I question. The PGI-I, validated for use in urinary incontinence and pelvic organ prolapse, 10,13 asked subjects to ''Check the number that best describes how your urinary condition is now compared with how it was before you began this study.'' Answers varied from ''very much better = 1'' to ''very much worse = 7'' on a 7-point Likert scale. Subjects were also asked to rate the helpfulness of their intervention on a 0-to 10-point Likert scale (0 = not helpful, 10 = extremely helpful). Outcome measures included withinand between-group comparisons of the questionnaires and voiding diaries.
Statistical Analysis
Analysis was performed using the Fisher exact test for categorical variables, t tests assuming unequal variance for continuous variables, and Wilcoxon rank test for ordinal variables with significance set at P G 0.05 (SAS version 9.2, Copyright\ 2009; SAS Institute, Cary, NC). Differences between groups' OAB-q SF scores and voiding frequencies at baseline and follow-up were evaluated, and changes were compared.
RESULTS
Thirty-two women were invited to participate in the study, and 10 declined, citing time constraints as the reason. Twentytwo women were enrolled in this exploratory study. Eleven were randomized to the hypnotherapy group, and 11 to the behavioral-therapyYalone group (Fig. 1) . Two women, one assigned to the hypnotherapy group and the other assigned to the behavioral therapy group, withdrew from the study before receiving their assigned therapies; they cited inability to keep their scheduled appointments as the reason. The 2 dropouts did not differ from the subjects who continued the study regarding age (40. 18.5] , P = 0.78). The 2 women who withdrew from the study did not receive any treatment and were excluded from the analysis. Twenty women completed the study and kept all scheduled appointments. At study completion, there were no reported complications or complaints regarding either of the treatment interventions. There were no differences between the hypnotherapy and the behavioral therapy groups' ages, ethnicity, and parity (Table 1) . Neither were there differences between the groups' medical history, history of hysterectomy, or incontinence surgery (Table 1 ).
There were no differences between groups' history of prior OAB treatment except in prior use of pelvic floor exercise, where the majority of subjects treated with behavioral therapy alone had previously performed pelvic floor exercise ( Table 1) . None of the subjects had a history of prolapse surgery.
The OAB-q SF distress scores improved significantly in both groups following treatment ( Table 2 ). The behavioral-therapyY alone group's distress scores improved 37%, and the hypnotherapy group improved 53% over baseline (P = 0.03, P = 0.0002, respectively). The hypnotherapy group had significant improvement in OAB-q SF quality-of-life scores (67% over baseline, P G 0.001), whereas the behavioral therapy group did not (42% over baseline, P = 0.05). Both groups decreased their voiding frequency following treatment. Mean voids decreased 15% in the behavioral-therapyYalone group, and 21% in the hypnotherapy group (Table 2) .
Between-group comparisons were also performed. Following treatment, the hypnotherapy group had significantly greater improvement in their Global Impression of Improvement (PGI-I) scores than the behavioral therapy group (Table 3 ). The hypnotherapy group's Global Impression of Improvement mean score represented answers of ''much better,'' and the behavioral therapy group's mean score represented answers of ''a little better.'' There were no differences between groups' baseline OAB-q SF distress (P = 0.55) and quality-of-life scores (P = 0.66) (baseline and follow-up scores noted in Table 2 ). Similarly, there were no differences between groups' change in OAB-q SF distress or qualityof-life scores following treatment, nor were there differences between the 2 groups' baseline voiding frequency (P = 0.16) (baseline frequency is noted in Table 2 ) and change in voiding frequency (P = 0.17) (posttreatment voiding frequency is noted in Table 2 ; between-group differences are noted in Table 3 ).
DISCUSSION
Patients had significant improvement in OAB based on validated questionnaires (37%Y67% improvement from baseline scores) and voiding diaries (15%Y21% improvement) following both hypnotherapy and behavioral therapy alone. This pilot study is notable in that the hypnotherapy group had superior global improvement in their OAB symptoms compared with behavioral therapy alone. Thus, hypnotherapy is a useful adjunct to behavioral therapy, a proven and accepted first-line treatment of OAB. 14 Prior data regarding hypnotherapy's use in lower urinary tract storage disorders are limited. In small trials, hypnotherapy has been reported to be useful in treating childhood enuresis. 15 Only a single study has described hypnotherapy's efficacy in treating women with OAB. In Freeman and Baxby's 9 observational study, urge incontinent women were treated with 12 hypnotherapy sessions administered over 1 month. Despite a much less intense regimen in our study, we were able to show benefit over standard therapy. Additional hypnotherapy sessions may have resulted in greater therapeutic benefit, and we plan to further evaluate their potential benefit in future studies.
This pilot study was designed as an exploratory evaluation of hypnotherapy and is therefore limited by the relatively small number of participants. Post hoc evaluation of the OAB-q SF quality-of-life scores indicates that 72 subjects (36 per group) would have been necessary to find the 25% difference that existed between the hypnotherapy and behavioral therapy group's scores to be significant, assuming 80% power and > = 0.05 with the observed effect size = 0.68. The finding of superior patient Global Impression of Improvement scores following hypnotherapy compared with behavioral therapy alone is remarkable, given the small number of patients in this study. The finding is noteworthy as patient global ratings provide the single best measure of the significance of change from the individual perspective, particularly when used as a longitudinal disease-related measure. 16 A limitation of the current study was absence of double blinding. Subjects knew which interventions they received. Absent monetary or other incentives, we believed recruitment would have been hindered had subjects received a sham intervention without known treatment benefit. A larger trial offering appropriate patient incentives would make sham therapies more acceptable. In addition, as in any randomized trial, selection bias may have occurred as subjects were willing to participate in randomization, so these subjects may not represent the general population. Last, because of the smaller numbers of subjects in this pilot study, randomization did not equalize all baseline variables (eg, history of prior OAB treatments), which could have also introduced bias into the study.
The study has several strengths. Subjects were randomized to the interventions, both groups received individualized treatment sessions, and validated outcome measures were used to quantify the effects of the treatments. Given these strengths, the study offers encouraging preliminary data regarding efficacy and acceptance of hypnotherapy as a novel treatment of OAB.
Hypnotherapy's therapeutic effect on urinary urgency is unknown, although it is likely mediated by central effects on the brain. Recent work with functional brain imaging has highlighted the importance of the brain in coordinating responses to bladder sensation and has shown that patients with urge incontinence differ from controls in cerebral cortical response to bladder distension. 17 Hypnotherapy, as postulated to occur following sacral neuromodulation, may modify the brain's response to bladder storage sensations. 18 The brain and its possible upregulation to afferent signal are increasingly hypothesized to play a central role in OAB pathophysiology. 17 This suggests that OAB treatment should be refocused upon the brain and its downregulation. Direct modification of the brain's response to bladder filling with hypnosis offers a novel approach to a prevalent problem often refractory to treatment. A larger trial comparing hypnotherapy to accepted OAB therapies could potentially add complementary alternative medicine techniques to the OAB armamentarium and increase insight into the role of the mind in OAB treatment.
